Inhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells
Qiaoli Zhao(Johannes Gutenberg University Mainz), Thomas Efferth(Johannes Gutenberg University Mainz)
Cited by 84
Related Papers
The role of p53 in cancer drug resistance and targeted chemotherapy
|Oncotarget|2016|580
Potential of Central, Eastern and Western Africa Medicinal Plants for Cancer Therapy: Spotlight on Resistant Cells and Molecular Targets
|Frontiers in Pharmacology|2017|142
Anti-Proliferative and Apoptosis-Inducing Effect of Theabrownin against Non-small Cell Lung Adenocarcinoma A549 Cells
|Frontiers in Pharmacology|2016|56
Ginkgolic acids inhibit migration in breast cancer cells by inhibition of NEMO sumoylation and NF-κB activity
|Oncotarget|2017|54
Theabrownin Inhibits Cell Cycle Progression and Tumor Growth of Lung Carcinoma through c-myc-Related Mechanism
|Frontiers in Pharmacology|2017|52